Should I Get Genetic Testing for Prostate Cancer?

July 24, 2019

According to the American Cancer Society, it is estimated that there will be about 175,000 new cases of prostate cancer diagnosed in 2019. About one out of every nine (12%) men in general will be diagnosed with prostate cancer in his lifetime, and that number rises to one in six (17%) for black or African American men specifically. Most often, prostate cancer happens sporadically, with no clear reason why the cancer started. However, sometimes prostate cancer can be seen running in a family in a hereditary manner, being passed down from generation to generation. Around 5-10% of prostate cancer diagnoses can be considered part of a hereditary cancer predisposition syndrome.

Read More Categories: Genetic Testing, Prostate Cancer

When Should Men Get a Prostate Cancer Screening?

May 4, 2018

Prostate cancer is the most common [non-skin] cancer in men. Therefore, it’s important to when to some facts about prostate cancer screenings, and make sure you, or the males in your life, are getting screened for prostate cancer in a timely manner.

Early Detection of Prostate Cancer Changes Outcomes for Patients!

Many perfectly healthy men are screened for prostate cancer as part of their regular health care routine. Doctors sometimes recommend testing simply because of age or family history. Other times, patients have some symptoms, and their doctor may suggest a prostate cancer screening as the first step to understanding the problem.

Read More Categories: Cancer Screening, Prostate Cancer

The Evolution of Genetic Testing and Immunotherapy in Prostate Cancer

March 1, 2018

By Mark T. Fleming, MD

Genetic testing for cancer and targeted drug therapy regimens have changed how multiple cancers, particularly breast cancer, colon cancer, and lung cancers are cared for. More and more, we are finding similar benefits in the diagnosis and treatment of prostate cancer.

High-quality genetic testing now can accurately pinpoint both hereditary and somatic mutations, providing crucial insights into how prostate cancer develops and grows. At the same time, new medications tailored to specific mutations have shown great promise in clinical trials, especially in a metastatic disease that has not responded to standard androgen-deprivation therapy.

Read More Categories: Genetic Testing, Prostate Cancer, Cancer Treatment

1